| 1 |
33188625 | Regulation of peroxisome proliferator-activated receptor-gamma activity affects the hepatic stellate cell activation and the progression of NASH via TGF-β1/Smad signaling pathway. | 2021 Feb |
1 |
| 2 |
34645125 | Lobeglitazone, A Peroxisome Proliferator-Activated Receptor-Gamma Agonist, Inhibits Papillary Thyroid Cancer Cell Migration and Invasion by Suppressing p38 MAPK Signaling Pathway. | 2021 Oct |
3 |
| 3 |
32155364 | Re: Rosiglitazone Suppresses Calcium Oxalate Crystal Binding and Oxalate-Induced Oxidative Stress in Renal Epithelial Cells by Promoting PPAR-γ Activation and Subsequent Regulation of TGF-β1 and HGF Expression. | 2020 Jun |
1 |
| 4 |
31249661 | Label-free quantitative proteomics identifies transforming growth factor β1 (TGF-β1) as an inhibitor of adipogenic transformation in OP9-DL1 cells and primary thymic stromal cells. | 2019 |
5 |
| 5 |
28337819 | PAI-1 in granulosa cells is suppressed directly by statin and indirectly by suppressing TGF-β and TNF-α in mononuclear cells by insulin-sensitizing drugs. | 2017 Jul |
1 |
| 6 |
28592228 | Anti-fibrogenic effect of PPAR-γ agonists in human intestinal myofibroblasts. | 2017 Jun 7 |
1 |
| 7 |
29049722 | A PPAR-Gamma Agonist Rosiglitazone Suppresses Fibrotic Response in Human Pterygium Fibroblasts by Modulating the p38 MAPK Pathway. | 2017 Oct 1 |
5 |
| 8 |
29285239 | Low density lipoprotein - rosiglitazone - chitosan-calcium alginate/nanoparticles inhibition of human tenon's fibroblasts activation and proliferation. | 2017 Dec 1 |
2 |
| 9 |
26734075 | Effects of nateglinide and rosiglitazone on pancreatic alpha- and beta-cells, GLP-1 secretion and inflammatory markers in patients with type 2 diabetes: randomized crossover clinical study. | 2016 |
1 |
| 10 |
25144187 | Rosiglitazone inhibits TGF-β 1 induced activation of human Tenon fibroblasts via p38 signal pathway. | 2014 |
4 |
| 11 |
22215258 | Rosiglitazone attenuates activation of human Tenon's fibroblasts induced by transforming growth factor-β1. | 2012 Aug |
3 |
| 12 |
22707243 | Rosiglitazone suppresses glioma cell growth and cell cycle by blocking the transforming growth factor-beta mediated pathway. | 2012 Oct |
2 |
| 13 |
21454487 | Peroxisome proliferator-activated receptor gamma ligands inhibit transforming growth factor-beta-induced, hyaluronan-dependent, T cell adhesion to orbital fibroblasts. | 2011 May 27 |
1 |
| 14 |
22174924 | Rosiglitazone inhibits transforming growth factor-β1 mediated fibrogenesis in ADPKD cyst-lining epithelial cells. | 2011 |
5 |
| 15 |
19710682 | A role for TGFbeta signaling in the pathogenesis of psoriasis. | 2010 Feb |
1 |
| 16 |
19923143 | Bradykinin and high glucose promote renal tubular inflammation. | 2010 Mar |
1 |
| 17 |
20205597 | Rosiglitazone inhibits migration, proliferation, and phenotypic differentiation in cultured human lung fibroblasts. | 2010 Mar |
3 |
| 18 |
19764552 | [The effect or rosiglitazone on signal pathways of transforming growth factor-beta1 in human lung fibroblast]. | 2009 Jul |
4 |
| 19 |
17922475 | Rosiglitazone increases matrix production and quenches inflammation: studies in human cells. | 2008 Mar-Apr |
2 |
| 20 |
18082740 | Transforming growth factor (TGF)-beta1-induced human endometrial stromal cell decidualization through extracellular signal-regulated kinase and Smad activation in vitro: peroxisome proliferator-activated receptor gamma acts as a negative regulator of TGF-beta1. | 2008 Oct |
2 |
| 21 |
18953895 | [Effect of Rosiglitazone on the proliferation and the production of transforming growth factor-beta 1 in cultured human Tenon' s capsule fibroblasts]. | 2008 May |
4 |
| 22 |
18044261 | A combination of a PPAR-gamma agonist and an angiotensin II receptor blocker attenuates proinflammatory signaling and stimulates expression of Smad7 in human peritoneal mesothelial cells. | 2007 Nov |
1 |
| 23 |
12711314 | c-Fos-driven transcriptional activation of transforming growth factor beta-1: inhibition of high glucose-induced promoter activity by thiazolidinediones. | 2003 May 2 |
1 |